Ross Okimoto
- University of California, San Francisco (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #15,231
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12193172Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-4467-8476Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$1.3M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#15,231
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Ross Okimoto as a PI. Multi-PI records show the full award amount for context.
- 4R37CA255453-06R37Contact PITherapeutic degradation of Capicua (CIC) fused oncoproteins in undifferentiated sarcomas$750.3Kaward amount
- 5R01CA299039-02R01Co-investigatorThe role of IL-6/STAT3 signaling in CIC-DUX4 fusion sarcoma metastasis and immunosuppression$573.5Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Ross Okimoto as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of California, San Francisco
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Ross Okimoto.